
Can-Fite BioPharma Ltd. CANF
€ 1.35
-1.99%
Land |
|
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NYSE AMERICAN |
Anteile |
1.65 M |
Marktkapitalisierung |
$ 2.44 M |
EBITDA (LTM) |
$ -9.93 M |
P/E (LTM) |
-0.247906 |
P/S (LTM) |
6.015773 |
EPS (LTM) |
-5.97 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals
IRWD
|
$ 4.79 | -1.75 % | $ 775 M | Nasdaq Global Select Market | ||
|
Fulcrum Therapeutics
FULC
|
$ 3.73 | -0.67 % | $ 284 M | Nasdaq Global Market | ||
|
Johnson & Johnson
JNJ
|
$ 272.65 | -2.17 % | $ 656 B | NYSE,SPB | ||
|
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
$ 94.99 | -0.13 % | $ 7.05 B | Nasdaq Global Select Market | ||
|
Kazia Therapeutics Limited
KZIA
|
$ 5.44 | 2.45 % | $ 82.9 M | Nasdaq Global Select Market | ||
|
Eli Lilly and Company
LLY
|
$ 1 381.41 | -2.41 % | $ 1.24 T | NYSE,SPB | ||
|
Immuron Limited
IMRN
|
$ 0.87 | -0.51 % | $ 201 M | Nasdaq Global Select Market | ||
|
Mesoblast Limited
MESO
|
$ 11.66 | -2.1 % | $ 14.1 B | Nasdaq Global Select Market | ||
|
Geron Corporation
GERN
|
$ 1.0 | -0.2 % | $ 667 M | Nasdaq Global Select Market | ||
|
Merck & Co.
MRK
|
$ 137.88 | -3.83 % | $ 345 B | NYSE,SPB | ||
|
Genmab A/S
GMAB
|
$ 50.93 | -1.98 % | $ 3.3 B | Nasdaq Global Select Market | ||
|
Moderna
MRNA
|
$ 196.67 | -4.9 % | $ 76.5 B | Nasdaq Global Select Market,SPB | ||
|
Gossamer Bio
GOSS
|
$ 11.37 | 2.99 % | $ 2.6 B | Nasdaq Global Select Market,SPB | ||
|
GeoVax Labs
GOVX
|
$ 1.99 | -1.24 % | $ 9.08 M | Nasdaq Global Select Market | ||
|
Grifols, S.A.
GRFS
|
$ 8.49 | -1.56 % | $ 5.77 B | Nasdaq Global Select Market | ||
|
Mirum Pharmaceuticals
MIRM
|
$ 92.52 | 0.62 % | $ 4.64 B | Nasdaq Global Select Market | ||
|
MediciNova
MNOV
|
$ 1.33 | -0.75 % | $ 65.3 M | Nasdaq Global Market | ||
|
InflaRx N.V.
IFRX
|
$ 1.11 | -3.48 % | $ 74.7 M | Nasdaq Global Select Market | ||
|
INmune Bio
INMB
|
$ 1.02 | 6.25 % | $ 25.3 M | Nasdaq Capital Market | ||
|
Ionis Pharmaceuticals
IONS
|
$ 27.39 | 1.59 % | $ 4.38 B | Nasdaq Global Select Market,SPB | ||
|
Jazz Pharmaceuticals plc
JAZZ
|
$ 246.57 | 2.43 % | $ 15 B | Nasdaq Global Select Market | ||
|
Nektar Therapeutics
NKTR
|
$ 34.77 | -3.17 % | $ 587 M | Nasdaq Global Select Market,SPB | ||
|
Kala Pharmaceuticals
KALA
|
$ 3.31 | -3.5 % | $ 27 M | Nasdaq Global Select Market | ||
|
Novartis AG
NVS
|
$ 155.26 | -2.43 % | $ 301 B | NYSE | ||
|
Omeros Corporation
OMER
|
$ 14.67 | 4.24 % | $ 932 M | Nasdaq Global Select Market | ||
|
Lineage Cell Therapeutics
LCTX
|
$ 0.84 | 3.54 % | $ 193 M | NYSE American | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
$ 298.84 | 1.71 % | $ 5.78 B | Nasdaq Global Select Market,SPB | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
$ 1.2 | 4.35 % | $ 54.8 M | Nasdaq Capital Market | ||
|
Mustang Bio
MBIO
|
$ 0.38 | -2.31 % | $ 1.87 M | Nasdaq Global Market | ||
|
Adagene
ADAG
|
$ 1.78 | 20.27 % | $ 105 M | Nasdaq Global Market | ||
|
Puma Biotechnology
PBYI
|
$ 7.22 | 1.12 % | $ 361 M | Nasdaq Global Select Market | ||
|
Denali Therapeutics
DNLI
|
$ 18.41 | 2.25 % | $ 3.18 B | Nasdaq Global Select Market,SPB | ||
|
Amarin Corporation plc
AMRN
|
$ 11.25 | -0.18 % | $ 4.67 B | Nasdaq Global Market | ||
|
ImmuCell Corporation
ICCC
|
$ 11.2 | -1.15 % | $ 101 M | Nasdaq Global Select Market | ||
|
Editas Medicine
EDIT
|
$ 1.77 | -3.29 % | $ 157 M | Nasdaq Global Select Market,SPB | ||
|
Agios Pharmaceuticals
AGIO
|
$ 29.7 | -0.64 % | $ 1.72 B | Nasdaq Global Select Market,SPB | ||
|
Pfizer
PFE
|
$ 28.06 | -1.46 % | $ 159 B | NYSE,SPB | ||
|
NuCana plc
NCNA
|
$ 0.82 | -7.71 % | $ 9.21 B | Nasdaq Global Select Market | ||
|
Equillium
EQ
|
$ 1.1 | -9.5 % | $ 63 M | Nasdaq Global Market | ||
|
Black Diamond Therapeutics
BDTX
|
$ 1.43 | -1.04 % | $ 81.3 M | Nasdaq Global Select Market,SPB | ||
|
Abeona Therapeutics
ABEO
|
$ 2.73 | 4.81 % | $ 145 M | Nasdaq Capital Market | ||
|
ACADIA Pharmaceuticals
ACAD
|
$ 18.0 | -1.77 % | $ 3.03 B | Nasdaq Global Select Market,SPB | ||
|
Atossa Therapeutics
ATOS
|
$ 1.8 | -5.26 % | $ 15.5 M | Nasdaq Capital Market | ||
|
Cleveland BioLabs, Inc.
CBLI
|
- | -7.31 % | $ 49 M | Nasdaq Capital Market | ||
|
Pliant Therapeutics
PLRX
|
$ 0.66 | 0.38 % | $ 40.5 M | Nasdaq Global Select Market | ||
|
Five Prime Therapeutics, Inc.
FPRX
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
ADC Therapeutics SA
ADCT
|
$ 1.33 | -1.48 % | $ 169 M | NYSE | ||
|
Harmony Biosciences Holdings
HRMY
|
$ 33.1 | 0.29 % | $ 1.9 B | Nasdaq Global Select Market | ||
|
Ardelyx
ARDX
|
$ 3.15 | -1.1 % | $ 759 M | Nasdaq Global Market | ||
|
Akebia Therapeutics
AKBA
|
$ 0.41 | 2.22 % | $ 105 M | Nasdaq Global Market |